Maha Katabi
CIK 1720685 · last filed 2025-05-16
Maha Katabi is a corporate insider who has filed 24 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing, for VERA, was dated May 16, 2025. Across all open-market trades the lifetime net is +$58.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $233.4M across reported positions. 11 SEC filings were submitted jointly with Sofinnova Management X, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$233.43M
5
24
$58.40M
Filer Profile
3000 SAND HILL ROAD, 4-250
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERA | Director | 7,062,846 | $33.05 | $233.43M | $4.90M | 10 | 2025-05-16 |
| Jade Biosciences, Inc. (AVTE) Delisted | Director | 97,187 | $93.80 | $9.12M | $5.00M | 8 | 2024-06-07 |
| RayzeBio, Inc. (RYZB) Delisted | Director | 0 | $62.49 | $0 | $8.50M | 3 | 2024-02-27 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 1,590,808 | $4.00 | $6.36M | $35.00M | 1 | 2020-07-28 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 856,262 | $13.29 | $11.38M | $5.00M | 1 | 2020-07-01 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-16 | VERA | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | VERA | Grant (A) | — | $0 | EDGAR |
| 2024-03-25 | VERA | Sell (S) | −834,459 | -$34.10M | EDGAR |
| 2024-03-21 | VERA | Notice (144) | −850,000 | -$38.53M | EDGAR |
| 2024-02-27 | RayzeBio, Inc. (RYZB) Delisted | Disp (D) | −2,419,528 | -$151.22M | EDGAR |
| 2024-02-01 | VERA | Buy (P) | +161,290 | $5.00M | EDGAR |
| 2024-01-04 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-17 | RayzeBio, Inc. (RYZB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-09-21 | RayzeBio, Inc. (RYZB) Delisted | Mixed | +2,419,528 | $8.50M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.